Effect of pharmacological treatment on outcomes of heart failure with preserved ejection fraction: an updated systematic review and network meta-analysis of randomized controlled trials.
藥物治療對保留射血分數心臟衰竭結果的影響:一項更新的隨機對照試驗的系統性回顧和網絡荟萃分析。
Cardiovasc Diabetol 2022-11-16
Cardiovascular and kidney outcomes of combination therapy with sodium-glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis.
二型糖尿病患者合併慢性腎臟病的鈉葡萄糖共同轉運蛋白-2抑制劑和礦物皮質激素受體拮抗劑聯合治療的心血管和腎臟結果:系統性回顧和網絡荟萃分析。
Diabetes Res Clin Pract 2022-12-21
The cardiovascular effects of SGLT2 inhibitors, RAS inhibitors, and ARN inhibitors in heart failure.
SGLT2抑制劑、RAS抑制劑和ARN抑制劑在心臟衰竭中的心血管效應。
ESC Heart Fail 2023-09-19
Influence of SGLT2i and RAASi and Their Combination on Risk of Hyperkalemia in DKD: A Network Meta-Analysis.
SGLT2i和RAASi及其組合對DKD高鉀風險的影響:網絡Meta分析。
Clin J Am Soc Nephrol 2023-10-12
MRAs may have lost their cornerstone position for heart failure treatment in the age of SGLT-2 inhibitors: A meta-analysis of randomized controlled trials.
SGLT-2 抑制劑時代下,MRAs 在心衰治療中可能已失去其基石地位:一項隨機對照試驗的荟萃分析。
Heart Fail Rev 2023-10-13
Differential effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose-response meta-analysis involving 10 randomized clinical trials and 71 553 individuals.
腎功能不同對鈉葡萄糖共轉運蛋白2抑制劑在心血管和腎臟結果上的差異影響:涉及10個隨機臨床試驗和71,553名個體的劑量反應荟萃分析。
Eur J Endocrinol 2023-08-04
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses.
鈉-葡萄糖共轉運蛋白-2 抑制劑對基線心血管-腎臟-代謝狀況下腎臟結果的影響:系統性回顧與統合分析。
J Am Soc Nephrol 2024-09-04